Back to Search Start Over

Novel discovery of schisandrin A regulating the interplay of autophagy and apoptosis in oligoasthenospermia by targeting SCF/c-kit and TRPV1 via biosensors.

Authors :
Ma, Lijuan
Li, Boyi
Ma, Jinchen
Wu, Chunyuan
Li, Nan
Zhou, Kailin
Yan, Yun
Li, Mingshuang
Hu, Xiaoyan
Yan, Hao
Wang, Qi
Zheng, Yanfei
Wu, Zhisheng
Source :
Acta Pharmaceutica Sinica B; Jun2023, Vol. 13 Issue 6, p2765-2777, 13p
Publication Year :
2023

Abstract

Oligoasthenospermia is the primary cause of infertility. However, there are still enormous challenges in the screening of critical candidates and targets of oligoasthenospermia owing to its complex mechanism. In this study, stem cell factor (SCF), c-kit, and transient receptor potential vanilloid 1 (TRPV1) biosensors were successfully established and applied to studying apoptosis and autophagy mechanisms. Interestingly, the detection limit reached 2.787 × 10<superscript>−15</superscript> g/L, and the quantitative limit reached 1.0 × 10<superscript>−13</superscript> g/L. Furthermore, biosensors were used to investigate the interplay between autophagy and apoptosis. Schisandrin A is an excellent candidate to form a system with c-kit similar to SCF/c-kit with a detection constant (K D) of 5.701 × 10<superscript>−11</superscript> mol/L, whereas it had no affinity for SCF. In addition, it also inhibited autophagy in oligoasthenospermia through antagonizing TRPV1 with a K D of up to 4.181 × 10<superscript>−10</superscript> mol/L. In addition, in vivo and in vitro experiments were highly consistent with the biosensor. In summary, high-potency schisandrin A and two potential targets were identified, through which schisandrin A could reverse the apoptosis caused by excessive autophagy during oligoasthenospermia. Our study provides promising insights into the discovery of effective compounds and potential targets via a well-established in vitro - in vivo strategy. Discovery of Schisandrin A regulating the interplay of autophagy and apoptosis of oligoasthenospermia by targeting the SCF/c-kit and TRPV1 via biosensors coupled with in vivo and in vitro investigation. [Display omitted] [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
22113835
Volume :
13
Issue :
6
Database :
Supplemental Index
Journal :
Acta Pharmaceutica Sinica B
Publication Type :
Academic Journal
Accession number :
164639061
Full Text :
https://doi.org/10.1016/j.apsb.2023.01.004